Re: Helene Hartvedt Grytli, Morten Wang Fagerland, Sophie D. Fossa, Kristin Austlid Tasken. Association Between Use of β-Blockers and Prostate Cancer-specific Survival: A Cohort Study of 3561 Prostate Cancer Patients with High-risk or Metastatic Disease. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2013.01.007.

被引：14

作者：

Bhaskaran, Krishnan ^{[1
]}

Rachet, Bernard ^{[1
]}

Evans, Stephen ^{[2
]}

Smeeth, Liam ^{[1
]}

机构：

[1] London Sch Hyg & Trop Med, Dept Noncommunicable Dis Epidemiol, London WC1B 3DP, England

[2] London Sch Hyg & Trop Med, Med Stat Dept, London WC1B 3DP, England

来源：

EUROPEAN UROLOGY | 2013年 / 64卷 / 04期

基金：

英国惠康基金;

关键词：

COMPETING RISKS; SUBDISTRIBUTION; MODELS;

D O I：

10.1016/j.eururo.2013.07.004

中图分类号：

R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：E86 / E87

页数：2

共 18 条

[1] Re: Helene Hartvedt Grytli, Morten Wang Fagerland, Sophie D. Fossa, Kristin Austlid Tasken. Association Between Use of β-Blockers and Prostate Cancer-specific Survival: A Cohort Study of 3561 Prostate Cancer Patients with High-risk or Metastatic Disease. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2013.01.007
Cardwell, Chris R.
Suissa, Samy
Murray, Liam J.
[J]. EUROPEAN UROLOGY, 2013, 64 (01) : E10 - E10
[2] Reply to Chris R. Cardwell, Samy Suissa and Liam J. Murray's Letter to the Editor re: Helene Hartvedt Grytli, Morten Wang Fagerland, Sophie D. Fossa, Kristin Austlid Tasken. Association Between Use of β-Blockers and Prostate Cancer-Specific Survival: A Cohort Study of 3561 Prostate Cancer Patients with High-Risk or Metastatic Disease. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2013.01.007
Grytli, Helene Hartvedt
Fagerland, Morten Wang
Fossa, Sophie D.
Tasken, Kristin Austlid
[J]. EUROPEAN UROLOGY, 2013, 64 (01) : E11 - E12
[3] Association Between Use of β-Blockers and Prostate Cancer-Specific Survival: A Cohort Study of 3561 Prostate Cancer Patients with High-Risk or Metastatic Disease
Grytli, Helene Hartvedt
Fagerland, Morten Wang
Fossa, Sophie D.
Tasken, Kristin Austlid
[J]. EUROPEAN UROLOGY, 2014, 65 (03) : 635 - 641
[4] Re: Par Stattin, Fredrik Sandin, Frederik Birkebaek Thomsen, et al. Association of Radical Local Treatment with Mortality in Men with Very High-risk Prostate Cancer: A Semiecologic, Nationwide, Population-based Study. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2016.07.023 Radical Treatment in Very High-risk Prostate Cancer: Venturing Down a Path Less Travelled
Santok, Glen Denmer
Rha, Koon Ho
[J]. EUROPEAN UROLOGY, 2017, 71 (04) : E113 - E114
[5] Re: Christina G. Jespersen, Mette Norgaard, Michael Borre. Androgen-deprivation Therapy in Treatment of Prostate Cancer and Risk of Myocardial Infarction and Stroke: A Nationwide Danish Population-based Cohort Study. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2013.02.002
Schooling, C. Mary
Sembajwe, Grace
Agalliu, Ilir
[J]. EUROPEAN UROLOGY, 2013, 64 (03) : E59 - E60
[6] Re: Malte Rieken, Shahrokh F. Shariat, Luis A. Kluth, et al. Association of Cigarette Smoking and Smoking Cessation with Biochemical Recurrence of Prostate Cancer in Patients Treated with Radical Prostatectomy. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2015.05.038
Froehner, Michael
Koch, Rainer
Wirth, Manfred P.
[J]. EUROPEAN UROLOGY, 2015, 68 (05) : E103 - E103
[7] Re: Meelan Bul, Xiaoye Zhu, Antti Rannikko, et al. Radical Prostatectomy for Low-Risk Prostate Cancer Following Initial Active Surveillance: Results From a Prospective Observational Study. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2012.02.002
Ates, Ferhat
Akyol, Ilker
Soydan, Hasan
[J]. EUROPEAN UROLOGY, 2012, 62 (01) : E9 - E9
[8] Reply to Hiten D. Patel and Mohamad E. Allaf's Letter to the Editor re: Maxine Sun, Andreas Becker, Zhe Tian, et al. Management of Localized Kidney Cancer: Calculating Cancer-specific Mortality and Competing Risks of Death for Surgery and Nonsurgical Management. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2013.03.034
Sun, Maxine
Karakiewicz, Pierre I.
Quoc-Dien Trinh
[J]. EUROPEAN UROLOGY, 2013, 64 (05) : E107 - E108
[9] Reply to Glen Denmer Santok and Koon Ho Rha's Letter to the Editor re: Par Stattin, Fredrik Sandin, Frederik Birkebaek Thomsen, et al. Association of Radical Local Treatment with Mortality in Men with Very High-risk Prostate Cancer: A Semiecologic, Nationwide, Population-based Study. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2016.07.023
Stattin, Par
Bratt, Ola
[J]. EUROPEAN UROLOGY, 2017, 71 (04) : E115 - E116
[10] Re: Sophie Knipper, Mehrdad Mehdi Irai, Ricarda Simon, et al. Cohort Study of Oligorecurrent Prostate Cancer Patients: Oncological Outcomes of Patients Treated with Salvage Lymph Node Dissection via Prostate-specific Membrane Antigen-radioguided Surgery. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2022.05.031
Montorsi, Francesco
Bravi, Carlo Andrea
Gandaglia, Giorgio
Mottrie, Alexandre
Briganti, Alberto
[J]. EUROPEAN UROLOGY, 2022, 82 (05) : E148 - E148

← 1 2 →